Neuphoria Therapeutics (NEUP) Other Non-Current Liabilities (2020 - 2026)
Neuphoria Therapeutics (NEUP) reported Other Non-Current Liabilities of $1.97 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 46.7% from $3.7 million a year earlier and down 19.8% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Dating back to fiscal Q4 2023, Neuphoria Therapeutics' Other Non-Current Liabilities record includes 10 quarters.
- Other Non-Current Liabilities has a three-year compound annual growth rate of -7.1% (FY2023 to FY2026).
- By fiscal year, Other Non-Current Liabilities came in at $3.7 million in FY2025 (-20.5%), $4.66 million in FY2024 (+89.6%) and $2.46 million in FY2023.
- The fiscal Q4 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since fiscal Q3 2025.
- Year over year, Other Non-Current Liabilities gained in three of the last five quarters, with growth averaging 115.2%.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $2.46 million (Q3 2026), $2.71 million (Q2 2026) and $8.09 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neuphoria Therapeutics | 335.34 Mn | 260.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.48 Mn |
| Dec 31, 2025 | 3.89 Mn |
| Sep 30, 2025 | 9.25 Mn |
| Jun 30, 2025 | 4.87 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Jun 30, 2024 | 5.25 Mn |
| Dec 31, 2023 | 3.61 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Jun 30, 2021 | 1.32 Mn |
| Jun 30, 2020 | -140,777.90 |
API Access
Neuphoria Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();